
Journal of Medicinal Chemistry p. 260 - 267 (1994)
Update date:2022-08-05
Topics:
Reddy, N. Laxma
Hu, Lain-Yen
Cotter, Ronald E.
Fischer, James B.
Wong, Wen Jee
et al.
Diarylguanidines, acting as NMDA receptor ion channel site ligands, represent a new class of potential neuroprotective drugs.Several diarylguanidines structurally related to N,N'-di-o-tolylguanidine (DTG), a known selective ? receptor ligand, were synthes
View MoreZhejiang Newfine Industry Co.,Ltd.
Contact:+86-573-82262042
Address:No.225,Dongqing Road, garoms@163.com
Taizhou Sunny Chemical Co.,Ltd
Contact:+86-523-86920899 +86-13951172783
Address:No.11 Xingyuang road, Gaoyong Chemical Industry Park, Gaogang Jiangsu China
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Jiangsu Willing Bio-Tech Co ltd
website:http://www.willingbio.com/
Contact:+86 18796908173
Address:No 18 Guoqiao Road
Guangzhou Swan Chemical Co., Ltd.
Contact:+86-20-31075659
Address:NO.301, Hong ba fang investment BLDG 1,Guan chong village,Shiqi town,Panyu district,Guangzhou
Doi:10.1007/BF00515428
(1986)Doi:10.1021/ol101147b
(2010)Doi:10.1016/0022-328X(86)84037-2
(1986)Doi:10.1016/j.tetasy.2008.05.024
(2008)Doi:10.1016/S0040-4020(99)00996-5
(1999)Doi:10.1128/AAC.01326-07
(2008)